The Impact of Naloxone Coprescribing Mandates on Opioid-Involved Overdose Deaths

This publication has 46 references indexed in Scilit:

• Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia
  Journal of the American Pharmacists Association, 2017
• Pharmacists’ role in opioid overdose: Kentucky pharmacists’ willingness to participate in naloxone dispensing
  Journal of the American Pharmacists Association, 2017
• Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report
  Cannabis & Cannabinoid Research, 2017
• Effectiveness of Scotland's National Naloxone Programme for reducing opioid‐related deaths: a before (2006–10) versus after (2011–13) comparison
  Addiction, 2016
• Legal changes to increase access to naloxone for opioid overdose reversal in the United States
  Drug and Alcohol Dependence, 2015
• An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions
  BMC Pharmacology and Toxicology, 2014
• The Feasibility of Pharmacy-Based Naloxone Distribution Interventions: A Qualitative Study With Injection Drug Users and Pharmacy Staff in Rhode Island
  Substance Use & Misuse, 2013
• Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis
  BMJ, 2013
• Pharmacy Participation in Non-Prescription Syringe Sales in Los Angeles and San Francisco Counties, 2007
  Journal of Urban Health, 2010
• Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies
  Journal of the American Pharmacists Association, 2010